A detailed history of Paradigm Capital Management Inc transactions in Standard Biotools Inc. stock. As of the latest transaction made, Paradigm Capital Management Inc holds 550,000 shares of LAB stock, worth $913,000. This represents 0.05% of its overall portfolio holdings.

Number of Shares
550,000
Previous 550,000 -0.0%
Holding current value
$913,000
Previous $973,000 9.04%
% of portfolio
0.05%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.87 - $2.78 $935,000 - $1.39 Million
500,000 Added 1000.0%
550,000 $1.49 Million
Q4 2023

Feb 13, 2024

BUY
$1.59 - $2.73 $79,500 - $136,500
50,000 New
50,000 $110,000
Q1 2022

May 25, 2022

SELL
$2.8 - $3.96 $2.16 Million - $3.05 Million
-771,100 Closed
0 $0
Q4 2021

Feb 09, 2022

SELL
$3.63 - $6.13 $525,987 - $888,237
-144,900 Reduced 15.82%
771,100 $3.02 Million
Q3 2021

Nov 08, 2021

SELL
$5.5 - $7.41 $5.04 Million - $6.79 Million
-916,000 Closed
0 $0
Q2 2021

Aug 05, 2021

SELL
$4.35 - $6.35 $1.43 Million - $2.09 Million
-329,000 Reduced 26.43%
916,000 $5.64 Million
Q1 2021

May 05, 2021

SELL
$3.94 - $7.09 $1.11 Million - $1.99 Million
-281,100 Reduced 18.42%
1,245,000 $5.63 Million
Q4 2020

Jan 20, 2021

BUY
$5.45 - $8.65 $2.95 Million - $4.69 Million
542,000 Added 55.08%
1,526,100 $9.16 Million
Q3 2020

Oct 20, 2020

SELL
$4.34 - $11.43 $2.26 Million - $5.96 Million
-521,600 Reduced 34.64%
984,100 $7.31 Million
Q2 2020

Aug 03, 2020

BUY
$1.85 - $5.29 $33,300 - $95,220
18,000 Added 1.21%
1,505,700 $6.04 Million
Q1 2020

May 12, 2020

BUY
$1.24 - $4.35 $1 Million - $3.52 Million
809,800 Added 119.46%
1,487,700 $3.78 Million
Q4 2019

Feb 05, 2020

BUY
$2.3 - $5.12 $1.27 Million - $2.83 Million
552,700 Added 441.45%
677,900 $2.36 Million
Q3 2019

Nov 07, 2019

BUY
$4.63 - $12.15 $579,676 - $1.52 Million
125,200 New
125,200 $580,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $131M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Paradigm Capital Management Inc Portfolio

Follow Paradigm Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Capital Management Inc with notifications on news.